ESC 365 - Improving kidney disease and cardiovascular outcomes with finerenone: from trials to clinical practice

Open Access

Improving kidney disease and cardiovascular outcomes with finerenone: from trials to clinical practice

Session: Finerenone: a disease-modifying therapy for heart and kidney protection

Topic: Clinical

Speaker: Professor G. Bakris (Chicago, US) Professor K. Marx-Schuett (Aachen, DE)

Sponsored by Bayer

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speakers

Professor George Bakris

University of Chicago Medicine, Chicago (United States of America)

6 presentations

2 followers

Professor Katharina Marx-Schuett

RWTH University Hospital Aachen, Aachen (Germany)

7 presentations

0 follower

4 more presentations in this session

Welcome and introductions

Speaker: Doctor M. Kosiborod (Kansas City, US)

The emerging common framework of a chronic heart-kidney disorder

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Investigating the potential effect of nonsteroidal MRA use in heart failure patient care

Speaker: Professor A. Voors (Groningen, NL) Doctor M. Kosiborod (Kansas City, US)

Q&A and close

Access the full session

Finerenone: a disease-modifying therapy for heart and kidney protection

Speakers: Professor G. Bakris, Professor K. Marx-Schuett, Doctor M. Kosiborod, Professor F. Zannad, Professor A. Voors...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources